About | Free Trial

Last Update


This profile was last updated on // .

Is this you? Claim your profile.

Wrong Renier Brentjens?

Dr. Renier Brentjens J.

Cancer Specialist

Sloan-Kettering Cancer Center

HQ Phone: (212) 639-2000

Sloan-Kettering Cancer Center

1275 York Avenue

New York, New York 10021

United States

Find other employees at this company (1,065)

Background Information

Employment History

Director, Cellular Therapeutics

Instructor In Medicine
Weill Cornell Medical College


Member of Laboratory



SUNY Buffalo

Web References (160 Total References)

Renier J. Brentjens, cancer ...

mycancerblogs.com [cached]

Renier J. Brentjens, cancer specialist at Memorial Sloan-Kettering Cancer Center, and his team treated f...

Juno Therapeutics Takes On Novartis With CAR-T Cell Therapy | Biotech Strategy Blog

biotechstrategyblog.com [cached]

Juno Therapeutics takes on Novartis and seeks to revolutionize the treatment of blood cancers - an interview with Renier Brentjens

One of the benefits of attending the American Society of Hematology (ASH) annual meeting that finished earlier this week in New Orleans is the opportunity to talk to experts who are at the forefront of their field.
Picture of Dr Renier Brentjens, Director of Cell Therapeutics, Memorial Sloan-Kettering Cancer Center
Renier Brentjens, MD PhD, is Director of Cell Therapeutics at Memorial Sloan-Kettering Cancer Center (MSKCC) and one of the scientific founders of Juno Therapeutics (Juno), a start-up company that recently raised $120M in Series A financing.
Subscribers to premium content can login to read my interview with Renier Brentjens and listen to audio excerpts from what was a fascinating conversation about a new immunotherapy that has the potential to revolutionize hematology.

Alexandria Summit: Oncology 2013

www.alexandriasummit.com [cached]

Renier J. Brentjens, MD, PhD

Associate Member, Associate Attending Physician, Leukemia Service & Chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center
Renier J. Brentjens, MD, PhD, obtained an MD and PhD (microbiology) from SUNY Buffalo, completed residency in medicine at Yale New Haven Hospital, and a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC). Currently, Dr. Brentjens is an associate member on the faculty at MSKCC and an attending physician on the leukemia service.
As a medical oncology fellow during his training at MSKCC, Dr. Brentjens initiated the initial pre-clinical studies demonstrating the potential clinical application of autologous T cells genetically modified to target the CD19 antigen through the retroviral gene transfer of artificial T cell receptors termed chimeric antigen receptors (CARs). Following completion of his medical oncology training, Dr. Brentjens became the principal investigator (PI) of his own laboratory.
As a PI, Dr. Brentjens successfully translated these studies to the clinical setting, treating patients with relapsed CD19+ tumors including chronic lymphocytic leukemia (CLL) and B cell acute lymphoblastic leukemia (B-ALL). Ongoing pre-clinical research in the laboratory is focused on the further development of CAR modified T cells, designed to overcome the hostile immunosuppressive tumor microenvironment through the generation of "armored CAR T cells" currently being translated to the clinical setting as second-generation CAR modified T cell clinical trials. Additionally, work in Dr. Brentjens' lab has expanded this CAR technology to target additional tumor antigens expressed on other tumors, including targeting the MUC-16 antigen expressed on ovarian carcinomas as well as the more ubiquitous WT-1 tumor associated antigen.

ASH Meeting on Lymphoma Biology

www.hematology.org [cached]

Renier J. Brentjens, MD, PhD Memorial Sloan-Kettering Cancer Center, New York, NY

Renier J. Brentjens, MD, PhD ...

www.hematology.org [cached]

Renier J. Brentjens, MD, PhD Director, Cellular Therapeutics Center, Associate Attending Physician, Leukemia Service Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Drs. Park and Brentjens indicated no relevant conflict of interest. back to top

Similar Profiles

Other People with this Name

Other people with the name Brentjens

Cas Brentjens
Infor Inc

Bart Brentjens
Bart Brentjens

Casper Brentjens

Renier Brentjens
Imedex LLC

Karien Brentjens
Brandbaar, advies bij communicatie en branding

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory